IP Library Granted Patent US 9,127,046
Granted Patent B2
US 9,127,046 · App. 13/506,653 · Granted Sep 8, 2015

Secretion of antibodies without signal peptides from bacteria

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,127,046
App. No.
13/506,653
Granted
Sep 8, 2015
Kind
B2
Abstract

The present invention is directed generally to compositions and methods for obtaining secretion of antibodies or antigen-binding antibody fragments from prokaryotes without the need for a signal peptide through making use of mutant host strains with altered secretory properties. In particular, the invention provides host cells and methods for obtaining secretion of antibodies or antigen-binding antibody fragments from bacteria without the need for a signal peptide and provides diverse libraries of antibody sequence resulting from such methods. The invention additionally provides diverse libraries.

Claims (11)

1. A method for producing an antibody, comprising the steps of:

(a) culturing an E. coli host cell comprising a prlA4 (SEQ ID NO: 1) phenotype and at least one expression vector comprising a polynucleotide molecule encoding a heavy chain polypeptide of the antibody and a polynucleotide molecule encoding a light chain polypeptide of the antibody, under conditions that express the polynucleotide encoding the heavy chain polypeptide and the polynucleotide molecule encoding the light chain polypeptide of the antibody, wherein at least one of the polynucleotides encodes a polypeptide lacking a signal peptide,

(b) secreting the heavy chain polypeptide and the light chain polypeptide across a cytoplasmic membrane,

(c) forming the antibody from the heavy chain polypeptide and the light chain polypeptide, and

(d) isolating said antibody.

2. The method of claim 1 , wherein the antibody is selected from the group consisting of a human antibody, a mouse antibody, a rat antibody, a rabbit antibody, a camel antibody, a sheep antibody, a chimeric antibody, a humanized antibody, a fusion antibody, and an epitope-focused antibody.

3. The method of claim 1 , wherein the polynucleotides encoding the heavy chain polypeptide and the light chain polypeptide are present on different expression vectors.

4. The method of claim 1 , wherein the polynucleotides encoding the heavy chain polypeptide and the light chain polypeptide are both present on the same vector.

5. The method of claim 1 , wherein the polynucleotide encodes the heavy chain polypeptide lacking a signal peptide.

6. The method of claim 1 , wherein the polynucleotide encodes the light chain polypeptide lacking a signal peptide.

7. The method of claim 1 , wherein the polynucleotides encode the heavy and light chain polypeptides lacking signal peptides.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2020
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: HUMANIGEN, INC.
Reel/Frame 052920/0631 →
SECURITY INTEREST Recorded Jul 16, 2019
From: HUMANIGEN, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 049769/0067 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045788/0148 →
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2018
From: BLACK HORSE CAPITAL MASTER FUND LTD.
To: KALOBIOS PHARAMECUTICALS, INC.
Reel/Frame 045855/0533 →
SECURITY INTEREST Recorded Dec 22, 2016
From: KALOBIOS PHARAMECUTICALS, INC.
To: BLACK HORSE CAPITAL MASTER FUND LTD.
Reel/Frame 041181/0605 →
SECURITY INTEREST Recorded May 23, 2016
From: KALOBIOS PHARMACEUTICALS, INC.
To: BLACK HORSE CAPITAL, LP
Reel/Frame 038788/0266 →